Vertex One Asset Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Vertex One Asset Management’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$4.97M	Buy	+105,964	New	+$4.68M	1.14%	23

Other funds holding RARX

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vertex One Asset Management's RARX Position: Q4 2019 in Review

Vertex One Asset Management opened a new position in Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q4 2019: 105,964 shares worth $4.97M. The stake represents 1.14% of the portfolio and ranks #23 among its holdings.

146 funds tracked by Wall St. Rank hold RARX as of Q4 2019.

Vertex One Asset Management held 105,964 shares of Ra Pharmaceuticals, Inc. Common Stock worth $4.97M as of Q4 2019.
Ra Pharmaceuticals, Inc. Common Stock was a new Vertex One Asset Management position in Q4 2019.
Ra Pharmaceuticals, Inc. Common Stock made up 1.14% of Vertex One Asset Management's portfolio in Q4 2019, its #23 holding.
146 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Vertex One Asset Management's 13F filing for Q4 2019, filed 21 Jan 2020.